Pancreatic Cancer Research

ResearcherThe Ohio State University Wexner Medical CenterActive in the last 2 years

Harrison Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9126-1964; OpenAlex author ID A5100689989; NIH RePORTER profile ID 9768966. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
3
Labs led
2
Collaborators
25
Papers, trials and grants by year

2016: 2 papers · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 grant · 2021: none · 2022: none · 2023: 1 grant · 2024: none · 2025: none · 2026: 5 papers, 1 grant

Papers 8

  1. Quantitative dynamic contrast-enhanced magnetic resonance imaging for early assessment of treatment response in pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s00330-026-12810-2↗
  2. Reply to the Letter to the Editor: Methodological and biophysical concerns on quantitative DCE-MRI for early PDAC response assessment. Co-author DOI 10.1007/s00330-026-12986-7↗
  3. Serial ctDNA dynamics predict clinical outcomes in metastatic and locally advanced PDAC: a systematic review. Co-author DOI 10.3389/fonc.2026.1901721↗
  4. Correction: Serial ctDNA dynamics predict clinical outcomes in metastatic and locally advanced PDAC: a systematic review. Co-author DOI 10.3389/fonc.2026.1955091↗
  5. ProAgio, a Novel Integrin αvβ3 Targeted Cytotoxin, Suppresses Tumor Growth and Reprograms the PDAC Microenvironment Co-author DOI 10.64898/2026.01.15.699725↗
  6. Accurate Therapeutic Response Assessment of Pancreatic Ductal Adenocarcinoma Using Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging With a Poi… Co-author DOI 10.1097/rli.0000000000000505↗
  7. A Novel Imaging Biomarker Extracted from Fluorescence Microscopic Imaging of TRA-8/DR5 Oligomers Predicts TRA-8 Therapeutic Efficacy in Breast and Pancreatic C… Co-author DOI 10.1007/s11307-015-0913-x↗
  8. SPARC-Independent Delivery of Nab-Paclitaxel without Depleting Tumor Stroma in Patient-Derived Pancreatic Cancer Xenografts. Co-author DOI 10.1158/1535-7163.mct-15-0764↗

Grants 3

  1. DCE-MRI guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer R01CA290435↗
  2. Disposable Perfusion Phantom for Accurate DCE-MRI Measurement of Pancreatic Cancer Therapy Response UH3CA232820↗
  3. Disposable Perfusion Phantom for Accurate DCE-MRI Measurement of Pancreatic Cancer Therapy Response UG3CA232820↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bassel F. El‐Rayes · 2 shared papers, 2 shared grants, 2023–2026 · strength 2.28
  2. Ashiq Masood · 1 shared grant, 2026 · strength 1.00
  3. Supriya Peshin · 2 shared papers, 2026 · strength 0.63
  4. Mark P. Rubinstein · 2 shared papers, 2026 · strength 0.63
  5. Ehab Takrori · 2 shared papers, 2026 · strength 0.63
  6. Shafia Rahman · 2 shared papers, 2026 · strength 0.63
  7. Midhun Malla · 2 shared papers, 2026 · strength 0.51
  8. Mehmet Akce · 2 shared papers, 2026 · strength 0.51
  9. John Bart Rose · 2 shared papers, 2019–2026 · strength 0.34
  10. Desiree E. Morgan · 2 shared papers, 2019–2026 · strength 0.34
  11. Ashiq Masood · 1 shared paper, 2026 · strength 0.27
  12. Sujith Sarvesh · 1 shared paper, 2026 · strength 0.27
  13. Dhana Sekhar Reddy Bandi · 1 shared paper, 2026 · strength 0.27
  14. Karina Jin Yoon · 1 shared paper, 2026 · strength 0.27
  15. Ganji Purnachandra Nagaraju · 1 shared paper, 2026 · strength 0.27
  16. Jeremy B. Foote · 1 shared paper, 2026 · strength 0.27
  17. Zhi-Ren Liu · 1 shared paper, 2026 · strength 0.27
  18. Martin D. Holland · 1 shared paper, 2026 · strength 0.24
  19. Moh'd M. Khushman · 1 shared paper, 2026 · strength 0.24
  20. Dana Backlund Cardin · 1 shared paper, 2026 · strength 0.24
  21. Sushanth Reddy · 1 shared paper, 2026 · strength 0.24
  22. Donald J Buchsbaum · 2 shared papers, 2016 · strength 0.16
  23. Kurt R. Zinn · 2 shared papers, 2016 · strength 0.16
  24. Ravi Kumar Paluri · 1 shared paper, 2019 · strength 0.10
  25. Manuel M. Hidalgo · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.